NSAIDs may affect the inflammatory response in AD by the upregulation of the peroxisome proliferator γ (PPAR γ) nuclear transcription factor and by the downregulation of cyclooxygenase-1 and cyclooxygenase-2 [27–29]. This evidence concerns the gene PTGS1 and Alzheimer disease.